Local peripheral effects of μ-opioid receptor agonists in neuropathic pain in rats
Section snippets
Acknowledgments
Supported by grant PBZ-MN-001-/P05/2002 (I.O. and B.P.) and EU grant No. QLRT-2001-02919 (R.P.).
References (20)
- et al.
Loss of antiallodynic and antinociceptive spinal/supraspinal morphine synergy in nerve-injured rats: restoration by MK-801 or dynorphin antisera
Brain Res.
(1999) - et al.
Role of peri-axonal inflammation in the development of thermal hyperalgesia and guarding behavior in a rat model of neuropathic pain
Neurosci. Lett.
(1995) - et al.
Further evidence for a peripheral component in the enhanced antinociceptive effect of systemic morphine in mononeuropathic rats: involvement of kappa-, but not delta-opioid receptors
Eur. J. Pharmacol.
(1996) - et al.
Transport of opioid peptides into the central nervous system
J. Pharm. Sci.
(1998) - et al.
Interleukin-1 beta induces long-term increase of axonally transported opiate receptors and substance P
Neuroscience
(1995) - et al.
Evidence for a peripheral component in the enhanced antinociceptive effect of a low dose of systemic morphine in rats with peripheral mononeuropathy
Neuroscience
(1995) - et al.
Cross-tolerance between the different mu-opioid receptor agonists endomorphin-1, endomorphin-2 and morphine at the spinal level in the rat
Neurosci. Lett.
(2002) - et al.
Multiple mu opiate receptors
Life Sci.
(1986) - et al.
Peripheral effects of morphine in neuropathic rats: role of sympathetic postganglionic nerve fibers
Eur. J. Pharmacol.
(2001) - et al.
Spinal analgesic action of endomorphins in acute, inflammatory and neuropathic pain in rats
Eur. J. Pharmacol.
(1999)
There are more references available in the full text version of this article.
Cited by (81)
Mechanisms of placebo analgesia: A dual-process model informed by insights from cross-species comparisons
2018, Progress in NeurobiologyCitation Excerpt :Modulation of nociceptive signals occurs at multiple stages along pain processing pathways. For example, pain modulation can be achieved by a reduction of receptor potentials in the periphery (Janson and Stein, 2003; Labuz et al., 2007; Obara et al., 2004; Richardson et al., 1998), within the spinal cord (Eippert et al., 2009b; Goffaux et al., 2007; Matre et al., 2006; Sprenger et al., 2012), or in cortical regions that evaluate the meaning and context surrounding nociceptive signals (Krummenacher et al., 2010). Today, several descending pain-modulating networks have been identified.
Intestinal inflammation and pain management
2015, Current Opinion in PharmacologyOxycodone: A Current Perspective on Its Pharmacology, Abuse, and Pharmacotherapeutic Developments
2023, Pharmacological ReviewsPain pathways and potential new targets for pain relief
2022, Biotechnology and Applied Biochemistry
Copyright © 2004 Elsevier Ireland Ltd. All rights reserved.